Bristol-Myers Squibb Co (NYSE: BMY) started the day on Thursday, with a price increase of 7.09% at $45.62, before settling in for the price of $42.6 at the close. Taking a more long-term approach, BMY posted a 52-week range of $42.52-$63.33.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 456.78%. This publicly-traded company’s shares outstanding now amounts to $2.04 billion, simultaneously with a float of $2.03 billion. The organization now has a market capitalization sitting at $92.86 billion. At the time of writing, stock’s 50-day Moving Average stood at $45.41, while the 200-day Moving Average is $50.26.
Bristol-Myers Squibb Co (BMY) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – General Industry. Bristol-Myers Squibb Co’s current insider ownership accounts for 0.06%, in contrast to 82.26% institutional ownership. According to the most recent insider trade that took place on Sep 02 ’25, this organization’s EVP, Chief Financial Officer sold 56,000 shares at the rate of 47.33, making the entire transaction reach 2,650,480 in total value, affecting insider ownership by 167,379.
Bristol-Myers Squibb Co (BMY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.5 per share during the current fiscal year.
Bristol-Myers Squibb Co’s EPS increase for this current 12-month fiscal period is 456.78% and is forecasted to reach 6.05 in the upcoming year.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
Let’s observe the current performance indicators for Bristol-Myers Squibb Co (BMY). It’s Quick Ratio in the last reported quarter now stands at 1.11. Alongside those numbers, its PE Ratio stands at $18.41, and its Beta score is 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.95. Similarly, its price to free cash flow for trailing twelve months is now 6.37.
In the same vein, BMY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.48, a figure that is expected to reach 1.58 in the next quarter, and analysts are predicting that it will be 6.05 at the market close of one year from today.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
If we take a close look at the recent performances of Bristol-Myers Squibb Co (NYSE: BMY), its last 5-days Average volume was 21.51 million that shows progress from its year to date volume of 13.78 million. During the previous 9 days, stock’s Stochastic %D was recorded 33.24% While, its Average True Range was 64.39.
Raw Stochastic average of Bristol-Myers Squibb Co (BMY) in the period of the previous 100 days is set at 37.62%, which indicates a major fall in contrast to 93.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.85 that was lower than 1.00 volatility it exhibited in the past 100-days period.
